From Thomas Edison's 1,093 patents to today's daily breakthroughs in biotech, pharma and information technologies, New Jersey has an ongoing tradition of innovation.
New Jersey businesses continue to be among the national leaders in research and development, making more than five percent of the total R&D expenditures. These investments have lead to important breakthroughs and discoveries, with more than 3,300 new patents filed in 2004 alone.
With such convenient proximity to Wall Street, many of the nation’s leading financial service firms have also established or relocated headquarters here.
New Jersey is home to 15 of the largest of the world’s 20 largest pharmaceutical companies and is the 5th largest biotech center in the U.S., ranking among the nation's leaders for FDA approval of new drugs and biologics.
| |
Pfizer
Sanofi-Aventis
Merck & Co
Johnson & Johnson
Novartis AG
Bristol-Myers Squibb
Hoffmann-La Roche
Wyeth |
GlaxoSmithKline PLC
Abbott Laboratories
Schering-Plough Corp
Bayer Healthcare AG (Bayer Roche LLC)
Eisai, Inc.
Sankyo (now Daiichi Sankyo)
Schering AG (Berlex)
Novo Nordisk |
